Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)
China flag China · Delayed Price · Currency is CNY
14.15
+0.13 (0.93%)
Apr 28, 2026, 3:00 PM CST

SHA:603456 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,5531,5432,7493,2061,0951,121
Trading Asset Securities
-----26.06
Cash & Short-Term Investments
1,5531,5432,7493,2061,0951,147
Cash Growth
-43.69%-43.87%-14.27%192.71%-4.49%225.79%
Accounts Receivable
1,0821,1251,255997.69767.03850.02
Other Receivables
12.2411.6211.88.326.465.72
Receivables
1,0941,1371,2661,006773.49855.74
Inventory
1,4611,4161,9291,9592,0211,682
Other Current Assets
1,2571,442127.5142.55102.8787.38
Total Current Assets
5,3645,5376,0716,3143,9933,772
Property, Plant & Equipment
4,3384,3384,2743,7223,1442,645
Long-Term Investments
366.54199.65108.08121.88109.13101.07
Goodwill
12.3612.688.6110.11111.1170.35
Other Intangible Assets
464.05464.9516.11504.74454.03412.47
Long-Term Deferred Tax Assets
1.110.071.680.7524.4311.21
Long-Term Deferred Charges
42.3950.564.7673.269.0716.21
Other Long-Term Assets
--2.94.748.3812.15
Total Assets
10,58810,60311,12710,8527,9147,040
Accounts Payable
935.821,0681,4591,1981,245988.14
Accrued Expenses
120.9194.26202.63227.81201.85168.05
Short-Term Debt
90.0150.43--50.05498.84
Current Portion of Long-Term Debt
7.287.14201.937.77200.21-
Current Portion of Leases
--7.796.786.591.01
Current Income Taxes Payable
103.75103.3355.7455.378.875.37
Current Unearned Revenue
103.49111.2369.7575.4183.0849.64
Other Current Liabilities
39.9643.5749.8485.95348.37303.65
Total Current Liabilities
1,4011,5782,0461,6572,2142,085
Long-Term Debt
--194.25389.0583.99201.49
Long-Term Leases
4.786.058.0311.8910.63.25
Long-Term Unearned Revenue
151.37149.79139.89109.12101.297.31
Long-Term Deferred Tax Liabilities
73.3274.2987.47101.47106.2676.55
Other Long-Term Liabilities
4.64.6441.7650.7725.76-
Total Liabilities
1,6351,8122,5182,3192,5422,463
Common Stock
889.45889.45895.24899.49834.25832.6
Additional Paid-In Capital
4,2854,2854,3804,4992,0581,985
Retained Earnings
3,8123,6403,3503,1902,5151,802
Treasury Stock
-102-102-99.9-132.01-113.12-44.43
Comprehensive Income & Other
6.0411.7511.524.652.261.49
Total Common Equity
8,8908,7248,5378,4615,2974,577
Minority Interest
62.6766.4872.9171.9475.1-
Shareholders' Equity
8,9538,7918,6108,5335,3724,577
Total Liabilities & Equity
10,58810,60311,12710,8527,9147,040
Total Debt
102.0663.62412415.49351.44704.58
Net Cash (Debt)
1,4511,4792,3372,791743.98442.29
Net Cash Growth
-38.00%-36.69%-16.27%275.13%68.21%-
Net Cash Per Share
1.621.662.623.130.900.53
Filing Date Shares Outstanding
905.71891.14889.45899.49834.25832.6
Total Common Shares Outstanding
905.71891.14889.45899.49834.25832.6
Working Capital
3,9633,9604,0254,6581,7791,687
Book Value Per Share
9.829.799.609.416.355.50
Tangible Book Value
8,4148,2477,9327,8464,7324,094
Tangible Book Value Per Share
9.299.258.928.725.674.92
Buildings
--1,9661,7861,6121,562
Machinery
--4,6654,3504,0103,684
Construction In Progress
--1,5661,198839.25471.51
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.